BETHESDA, Md., April 6 — A drug very similar to Remicade was approved by the U.S. Food and Drug Administration for treatment of Crohn’s disease, rheumatoid arthritis, irritable bowel syndrome and other chronic conditions, the agency said. Inflectra is a biosimilar to Remicade, and while not a direct copy, it ... Read More »